Matched Unrelated Donor Transplantation Versus Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Children with Acute Myeloid Leukemia: A PDWP-EBMT Study

Scientists compared outcomes of patients under 18 years with AML in first and second complete remission undergoing a hematopoietic stem cell transplantation (HCT) either with a MUD with anti-thymocyte globuline or a haplo HCT with PT-CY after a myeloablative conditioning regimen between 2011 and 2021.